相关实验视频
Updated: Feb 28, 2026
10:18
Blue-hazard-free Candlelight OLED
Published on: March 19, 2017
9.9K
在基于显示的数字疗法中减轻蓝光风险:支持临床有效性的实际框架
1Division of Digital Healthcare, Yonsei University Mirae Campus, Wonju 26493, Republic of Korea.
Journal of clinical medicine
|February 27, 2026
概括
数字疗法 (DTx) 使用显示光,但蓝光可以扰乱睡眠和昼夜节律,影响健康. 优化显示灯光对于安全有效的治疗用途至关重要.
科学领域:
- 眼科医生 眼科 眼科
- 时间生物学 时间生物学
- 数字治疗学数字治疗学
背景情况:
- 基于显示的数字疗法 (DTx) 越来越多地用于各种疾病.
- 显示器的光学特性显著影响治疗剂量.
- 富含蓝色光的发射 (450-480纳米) 可以抑制黑激素并扰乱昼夜时间,可能降低治疗效率.
研究的目的:
- 审查显示启用DTx.的临床证据.
- 综合蓝光对睡眠,昼夜节律和相关健康结果的影响数据.
- 为治疗显示器的频谱优化提供信息.
主要方法:
- 对DTx.临床证据的文献审查.
- 关于蓝光生物效应的机械和实验数据的综合.
- 基于波长的视网膜光化学和忧郁症危险之间的区别.
主要成果:
- 暴露在蓝光中,特别是在晚上,会扰乱昼夜节律和黑激素的产生.
- 循环节障碍与情绪,认知,心血管健康,新陈代谢以及癌症/皮肤损伤风险增加的不良影响有关.
- 确定了波长特定的危险:415-450 nm (光化学) 和450-480 nm (黑色眼镜).
结论:
- 显示灯光特性对于DTx的有效性和安全性至关重要.
- 缓解策略包括频谱工程,光学过和软件控制.
- 将显示输出与治疗意图对齐,需要仔细设计,处方和标准化.
更多相关视频
09:03Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management
Published on: March 28, 2025
1.2K
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
10.0K
相关概念视频
01:29Therapeutic Drug Monitoring: Affecting Factors
288
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
288
01:16Therapeutic Drug Monitoring: Overview and Classification
445
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
445
01:11Blinding
4.0K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.0K